PURIFIED FACTOR-VIII - THEORETICAL ADVANTAGES, BUT AT A COST

被引:4
作者
TUDDENHAM, EGD [1 ]
LAFFAN, M [1 ]
机构
[1] HAMMERSMITH HOSP,CTR HAEMOPHILIA,LONDON W12 0NN,ENGLAND
关键词
D O I
10.1136/bmj.311.7003.465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:465 / 466
页数:2
相关论文
共 7 条
[1]  
DEBIASI R, 1992, BLOOD, V78, P1919
[2]  
FURIE B, 1994, BLOOD, V84, P3
[3]   RISKS OF IMMUNODEFICIENCY, AIDS, AND DEATH RELATED TO PURITY OF FACTOR-VIII CONCENTRATE [J].
GOEDERT, JJ ;
COHEN, AR ;
KESSLER, CM ;
EICHINGER, S ;
SEREMETIS, SV ;
RABKIN, CS ;
YELLIN, FJ ;
ROSENBERG, PS ;
ALEDORT, LM .
LANCET, 1994, 344 (8925) :791-792
[4]   RECOMBINANT FACTOR-VIII FOR THE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - SAFETY, EFFICACY, AND DEVELOPMENT OF INHIBITORS [J].
LUSHER, JM ;
ARKIN, S ;
ABILDGAARD, CF ;
SCHWARTZ, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (07) :453-459
[5]   HUMAN RECOMBINANT DNA-DERIVED ANTIHEMOPHILIC-FACTOR (FACTOR-VIII) IN THE TREATMENT OF HEMOPHILIA-A [J].
SCHWARTZ, RS ;
ABILDGAARD, CF ;
ALEDORT, LM ;
ARKIN, S ;
BLOOM, AL ;
BRACKMANN, HH ;
BRETTLER, DB ;
FUKUI, H ;
HILGARTNER, MW ;
INWOOD, MJ ;
KASPER, CK ;
KERNOFF, PBA ;
LEVINE, PH ;
LUSHER, JM ;
MANNUCCI, PM ;
SCHARRER, I ;
MACKENZIE, MA ;
PANCHAM, N ;
KUO, HS ;
ALLRED, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (26) :1800-1805
[6]   3-YEAR RANDOMIZED STUDY OF HIGH-PURITY OR INTERMEDIATE-PURITY FACTOR-VIII CONCENTRATES IN SYMPTOM-FREE HIV-SEROPOSITIVE HEMOPHILIACS - EFFECTS ON IMMUNE STATUS [J].
SEREMETIS, SV ;
ALEDORT, LM ;
BERGMAN, GE ;
BONA, R ;
BRAY, G ;
BRETTLER, D ;
EYSTER, ME ;
KESSLER, C ;
LAU, TS ;
LUSHER, J ;
RICKLES, F .
LANCET, 1993, 342 (8873) :700-703
[7]  
1992, BLOOD COAGUL FIBRIN, V3, P205